If you suspect you have experienced an adverse reaction to a GLP-1 receptor agonist, including gallbladder problems, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Researchers should consider incorporating resistance training and adequate protein intake to support muscle preservation during treatment
Safety and side effect profiles Both BPC-157 and TB-500 demonstrate favorable safety profiles across research applications and practical use
doi:10.1001/jamanetworkopen.2025.26321
Pottegrd A, Friis S, Strmer T, Hallas J, Bahmanyar S (2018) Considerations for pharmacoepidemiological studies of drug-cancer associations
Schelke L, Harris S, Cartier H, et al